UniProt P0C5C1
P0C5C1
P0C5C1 (UniProt P0C5C1): 48 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P0C5C1
- Experimental structures
- 48
- Predicted models
- 0
Structures
48 records of P0C5C1 in the MolNFT archive: 48 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 3CG5 | Crystal Structure of the Covalent Adduct Formed between TB B-lactamase and Clavulanate | x-ray diffraction | A | — | — |
| 3CG5 | Crystal structure of the covalent adduct formed between tb B-lactamase and clavulanate | x-ray diffraction | A | — | — |
| 3DWZ | Meropenem Covalent Adduct with TB Beta-lactamase | x-ray diffraction | A | — | — |
| 3DWZ | Meropenem covalent adduct with tb beta-lactamase | x-ray diffraction | A | — | — |
| 3IQA | Crystal Structure of BlaC covalently bound with Doripenem | x-ray diffraction | A | — | — |
| 3IQA | Crystal structure of blac covalently bound with doripenem | x-ray diffraction | A | — | — |
| 3M6B | Crystal Structure of the Ertapenem Pre-isomerized Covalent Adduct with TB B-lactamase | x-ray diffraction | A | — | — |
| 3M6B | Crystal structure of the ertapenem pre-isomerized covalent adduct with tb B-lactamase | x-ray diffraction | A | — | — |
| 3M6H | Crystal Structure of Post-isomerized Ertapenem Covalent Adduct with TB B-lactamase | x-ray diffraction | A | — | — |
| 3M6H | Crystal structure of post-isomerized ertapenem covalent adduct with tb B-lactamase | x-ray diffraction | A | — | — |
| 3N6I | Crystal Structure of BlaC-E166A covalently bound with 6-aminopenicillian | x-ray diffraction | A | — | — |
| 3N6I | Crystal structure of blac-E166A covalently bound with 6- aminopenicillian | x-ray diffraction | A | — | — |
| 3N7W | Crystal Structure of BlaC-E166A covalently bound with Amoxicillin | x-ray diffraction | A | — | — |
| 3N7W | Crystal structure of blac-E166A covalently bound with amoxicillin | x-ray diffraction | A | — | — |
| 3N8L | Crystal Structure of BlaC-E166A covalently bound with Ampicillin | x-ray diffraction | A | — | — |
| 3N8L | Crystal structure of blac-E166A covalently bound with ampicillin | x-ray diffraction | A | — | — |
| 3N8R | Crystal Structure of BlaC-E166A covalently bound with Carbenicillin | x-ray diffraction | A | — | — |
| 3N8R | Crystal structure of blac-E166A covalently bound with carbenicillin | x-ray diffraction | A | — | — |
| 3N8S | Crystal Structure of BlaC-E166A covalently bound with Cefamandole | x-ray diffraction | A | — | — |
| 3N8S | Crystal structure of blac-E166A covalently bound with cefamandole | x-ray diffraction | A | — | — |
| 3NBL | Crystal Structure of BlaC-E166A covalently bound with Cefuroxime | x-ray diffraction | A | — | — |
| 3NBL | Crystal structure of blac-E166A covalently bound with cefuroxime | x-ray diffraction | A | — | — |
| 3NC8 | Crystal Structure of BlaC-E166A covalently bound with Mecillinam | x-ray diffraction | A | — | — |
| 3NC8 | Crystal structure of blac-E166A covalently bound with mecillinam | x-ray diffraction | A | — | — |
| 3NCK | Crystal Structure of BlaC-E166A covalently bound with Nafcillin | x-ray diffraction | A | — | — |
| 3NCK | Crystal structure of blac-E166A covalently bound with nafcillin | x-ray diffraction | A | — | — |
| 3NDE | Crystal Structure of BlaC-E166A covalently bound with Cephalotin | x-ray diffraction | A | — | — |
| 3NDE | Crystal structure of blac-E166A covalently bound with cephalotin | x-ray diffraction | A | — | — |
| 3NDG | Crystal Structure of BlaC-E166A covalently bound with Methicillin | x-ray diffraction | A | — | — |
| 3NDG | Crystal structure of blac-E166A covalently bound with methicillin | x-ray diffraction | A | — | — |
| 3NY4 | Crystal Structure of BlaC-K73A bound with Cefamandole | x-ray diffraction | A | — | — |
| 3NY4 | Crystal structure of blac-K73A bound with cefamandole | x-ray diffraction | A | — | — |
| 3VFF | BlaC E166A CDC-OMe Acyl-Intermediate Complex | x-ray diffraction | A, B, C, D | — | — |
| 3VFF | Blac E166A cdc-ome acyl-intermediate complex | x-ray diffraction | A, B, C, D | — | — |
| 3VFH | BlaC E166A CDC-1 Acyl-Intermediate | x-ray diffraction | A, B, C, D | — | — |
| 3VFH | Blac E166A cdc-1 acyl-intermediate | x-ray diffraction | A, B, C, D | — | — |
| 3ZHH | X-ray structure of the full-length beta-lactamase from M.tuberculosis | x-ray diffraction | A, B, C, D | — | — |
| 3ZHH | X-ray structure of the full-length beta-lactamase from M. tuberculosis | x-ray diffraction | A, B, C, D | — | — |
| 4DF6 | Crystal Structure of the inhibitor NXL104 Covalent Adduct with TB B-lactamase | x-ray diffraction | A | — | — |
| 4DF6 | Crystal structure of the inhibitor NXL104 covalent adduct with tb B- lactamase | x-ray diffraction | A | — | — |
| 4EBL | BlaC E166A Faropenem Acyl-Intermediate Complex | x-ray diffraction | A, B, C, D | — | — |
| 4EBL | Blac E166A faropenem acyl-intermediate complex | x-ray diffraction | A, B, C, D | — | — |
| 4EBN | BlaC Amoxicillin Acyl-Intermediate Complex | x-ray diffraction | A, B, C, D | — | — |
| 4EBN | Blac amoxicillin acyl-intermediate complex | x-ray diffraction | A, B, C, D | — | — |
| 4EBP | BlaC E166A Cefotaxime Acyl-Intermediate Complex | x-ray diffraction | A, B, C, D | — | — |
| 4EBP | Blac E166A cefotaxime acyl-intermediate complex | x-ray diffraction | A, B, C, D | — | — |
| 4JLF | Inhibitor resistant (R220A) substitution in the Mycobacterium tuberculosis beta-lactamase | x-ray diffraction | A | — | — |
| 4JLF | Inhibitor resistant (R220A) substitution in the mycobacterium tuberculosis beta-lactamase | x-ray diffraction | A | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.